Bristol-Myers Squibb Company
Large Cap · Healthcare · Drug Manufacturers - General
$63.85−$0.81 (-1.25%)
Bristol-Myers Squibb Company
Large Cap · Healthcare · Drug Manufacturers - General
$63.85−$0.81 (-1.25%)
Stock analysis
Get the AI take on BMY
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$42.52
High$62.89
Today $63.85
RSI (14)
56.5Neutral
03070100
Overall score
61/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Lowest
$40
Current price
$63.85
Median target
$68
Highest
$80
LowHigh
Operating Record
Revenue
What's working
- Forward P/E: Investors aren't pricing in much earnings growth, so there's room to be pleasantly surprised.
- Price / sales: You're paying a modest amount for each dollar of revenue coming in.
What to watch
- Debt exceeds cash by $33.6B, increasing balance-sheet pressure, a warning sign.
- Debt / equity: Heavy borrowing means a downturn would hit harder than it otherwise would.
What the market charges
Forward P/E
Favorable · 48% below avg
9.94x
Price / sales
Strong · Priced modestly against the revenue it brings in
2.65x
Price / FCF
Strong · Priced well within what its cash flow supports
11.40x
EV / EBITDA
Strong · Operating earnings comfortably support this price
8.66x
How efficiently it compounds
ROIC
Strong · Comfortably clears the bar for efficient capital use
21.7%
ROE
Favorable · 38.8% - strong capital efficiency
46.6%
Debt / equity
Needs attention · Unfavorable
2.02x
Current ratio
Strong · Comfortable room to cover bills due within a year
1.53x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $130.39B | 14.1 | +3.1% | 61 |
 | $11.53B | 22.0 | +19.7% | 78 |
 | $4.60B | 13.9 | +13.5% | 77 |
 | $33.87B | 35.4 | +15.5% | 77 |
 | $1.11T | 40.1 | +49.6% | 76 |